Using Fragment Cocktail Crystallography To Assist Inhibitor Design of Trypanosoma brucei Nucleoside 2-Deoxyribosyltransferase

Journal of Medicinal Chemistry
2006.0

Abstract

The 1.8 A resolution de novo structure of nucleoside 2-deoxyribosyltransferase (EC 2.4.2.6) from Trypanosoma brucei (TbNDRT) has been determined by SADa phasing in an unliganded state and several ligand-bound states. This enzyme is important in the salvage pathway of nucleoside recycling. To identify novel lead compounds, we exploited "fragment cocktail soaks". Out of 304 compounds tried in 31 cocktails, four compounds could be identified crystallographically in the active site. In addition, we demonstrated that very short soaks of approximately 10 s are sufficient even for rather hydrophobic ligands to bind in the active site groove, which is promising for the application of similar soaking experiments to less robust crystals of other proteins.

Knowledge Graph

Similar Paper

Using Fragment Cocktail Crystallography To Assist Inhibitor Design of Trypanosoma brucei Nucleoside 2-Deoxyribosyltransferase
Journal of Medicinal Chemistry 2006.0
Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
MedChemComm 2014.0
Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase
Bioorganic & Medicinal Chemistry 2010.0
Probing Hot Spots at Protein−Ligand Binding Sites:  A Fragment-Based Approach Using Biophysical Methods
Journal of Medicinal Chemistry 2006.0
A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors
European Journal of Medicinal Chemistry 2022.0
Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis
Journal of Medicinal Chemistry 2018.0
‘Tethering’ fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase
Bioorganic & Medicinal Chemistry Letters 2018.0
Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity
Journal of Medicinal Chemistry 2015.0
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity
Journal of Medicinal Chemistry 2018.0
Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2
Bioorganic & Medicinal Chemistry Letters 2016.0